Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dora Ng

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 31, 2024
Design, Synthesis, and Evaluation of BCL-2 Targeting PROTACsAleša Bricelj, Yuen Lam Dora Ng, Martina Gobec, et al.
Chemical Science|November 2, 2020
Systematic exploration of different E3 ubiquitin ligases: an approach towards potent and selective CDK6 degradersChristian Steinebach, Yuen Lam Dora Ng, Izidor Sosič, et al.
Nature Communications|February 24, 2022
Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myelomaYuen Lam Dora Ng, Evelyn Ramberger, Stephan R Bohl, et al.
Chemmedchem|December 16, 2025
A Facile Protocol for C(sp<sup>2</sup>)-C(sp<sup>3</sup>) Bond Formation Reactions Toward Functionalized E3 Ligase LigandsAnita Maksutova, Thomas M Geiger, Lorenzo Cianni, et al.
Journal of Medicinal Chemistry|October 30, 2023
Leveraging Ligand Affinity and Properties: Discovery of Novel Benzamide-Type Cereblon Binders for the Design of PROTACsChristian Steinebach, Aleša Bricelj, Arunima Murgai, et al.
Blood Advances|August 2, 2022
SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myelomaGuus J J E Heynen, Francis Baumgartner, Michael Heider, et al.
Nature Cancer|June 28, 2024
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunitiesEvelyn Ramberger, Valeriia Sapozhnikova, Yuen Lam Dora Ng, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 31, 2024
Design, Synthesis, and Evaluation of BCL-2 Targeting PROTACsAleša Bricelj, Yuen Lam Dora Ng, Martina Gobec, et al.
Chemical Science|November 2, 2020
Systematic exploration of different E3 ubiquitin ligases: an approach towards potent and selective CDK6 degradersChristian Steinebach, Yuen Lam Dora Ng, Izidor Sosič, et al.
Nature Communications|February 24, 2022
Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myelomaYuen Lam Dora Ng, Evelyn Ramberger, Stephan R Bohl, et al.
Chemmedchem|December 16, 2025
A Facile Protocol for C(sp<sup>2</sup>)-C(sp<sup>3</sup>) Bond Formation Reactions Toward Functionalized E3 Ligase LigandsAnita Maksutova, Thomas M Geiger, Lorenzo Cianni, et al.
Journal of Medicinal Chemistry|October 30, 2023
Leveraging Ligand Affinity and Properties: Discovery of Novel Benzamide-Type Cereblon Binders for the Design of PROTACsChristian Steinebach, Aleša Bricelj, Arunima Murgai, et al.
Blood Advances|August 2, 2022
SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myelomaGuus J J E Heynen, Francis Baumgartner, Michael Heider, et al.
Nature Cancer|June 28, 2024
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunitiesEvelyn Ramberger, Valeriia Sapozhnikova, Yuen Lam Dora Ng, et al.
Pageof 2